Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'
A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).
According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.
THIS IS A BREAKING STORY. UPDATES SOON
Maharashtra CM Devendra Fadnavis Vows To Identify, Deport Bangladeshi Infiltrators To Make City Safer
BMC Elections 2026: Maharashtra BJP’s Ravindra Chavan Admits Regret Over Ajit Pawar’s Induction
MTNL Floats RFP To Sell Kemps Corner Office Property For ₹25.71 Crore
Mumbai Consumer Commission Orders Thane Developer To Refund ₹7.92 Lakh For Delay In Sale Agreement Registration
